Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
PureTech Health PLC
0VQ0Current price
19.2 EUR
-1.4 EUR (-6.80%)
Last closed
21.77 USD
Company
www.puretechhealth.com
ISIN
US7462371060
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
499 192 800 USD
Yield for 12 month
+4.33 %
1Y
3Y
5Y
10Y
15Y
0VQ0
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. Address: 6 Tide Street, Boston, MA, United States, 02210
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
52.75 USDP/E ratio
–Dividend Yield
–Current Year
+3 330 000 USD
Last Year
+2 090 000 USD
Current Quarter
+144 000 USD
Last Quarter
+144 000 USD
Current Year
-1 603 000 USD
Last Year
-150 343 000 USD
Current Quarter
-19 320 000 USD
Last Quarter
-19 320 000 USD
Key Figures 0VQ0
1 year
3 years
5 years
10 years
EBITDA
-134 728 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.39 %
PEG Ratio
–
Return On Equity TTM
-22.07 %
Wall Street Target Price
52.75 USD
Revenue TTM
468 000 USD
Book Value
1.32 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-90.9 %
Dividend Yield
–
Gross Profit TTM
17 388 000 USD
Earnings per share
-3 USD
Diluted Eps TTM
-3 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
61.5 %
Profit Margin
–
Dividend Analytics 0VQ0
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0VQ0
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 0VQ0
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
348.8244
Price Sales TTM
1066.6512
Enterprise Value EBITDA
-51.9348
Price Book MRQ
1.5804
Financials 0VQ0
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0VQ0
For 52 weeks
17.08 USD
34 USD
50 Day MA
20.39 USD
Shares Short Prior Month
7 025
200 Day MA
24.44 USD
Short Ratio
0.88
Shares Short
5 291
Short Percent
0.05 %
BeatStart